Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors

Hepato-Gastroenterology

Volumn 58, Issue 105, 2011, Pages 76-80

  Menéndez Sánchez, Pablo ^a   Padilla, D ^a   Cubo, T ^a   Villarejo, P ^a   Gambi D ^a   Menendez J M ^b   Colina, F ^b   Garcia, M ^a   Lora, D ^b   Martin J ^a  

^a Hospital General   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Gastrointestinal stromal tumor; Ki67; Mortality; p53

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P53; PROTEIN S 100; SMOOTH MUSCLE ACTIN; VASCULOTROPIN RECEPTOR; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER RISK; CELL PROLIFERATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS; MORBIDITY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955040866     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, et al: NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007 Jul; 5 Suppl 2:S1-29; quiz S30.
2. Parfitt JR, Streutker CJ, Riddell RH, Driman DK: Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract. 2006; 202(12):837-47. (Pubitemid 44743077)
3. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002 May; 33(5):459-65. (Pubitemid 34747864)
4. Miettinen M, Lasota J: Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006 Oct; 130(10):1466-78. (Pubitemid 44520713)
5. Gómez Senent S, Gómez Raposo C, Segura Cabrai JM: Clinical and therapeutical management of gastrointestinal stromal tumors (GIST). Med Clin (Barc). 2006 Nov 4; 127(17):660-8.
6. Artigas-Raventos V, Lopez-Pousa A: Gastrointestinal stromal tumors: new concepts and multidisciplinary medico-surgical therapeutic strategies. Cir Esp. 2006 Jan; 79(1):1-2.
7. Tzen CY, Wang JH, Huang YJ, Wang MN, Lin PC, Lai GL, Wu CY, Tzen CY: Incidence of gastrointestinal stromal tumor: a retrospective study based on immunohistochemical and mutational analyses. Dig Dis Sci 2007 Mar; 52(3):792-7.
8. Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, et al: Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol. 2005 Apr; 16(4):566-78.
9. Beltran MA, Cruces KS: Primary tumors of jejunum and ileum as a cause of intestinal obstruction: a case control study. Int J Surg. 2007 Jun; 5(3):183-91. (Pubitemid 46727117)
10. Hu TH, Chuah SK, Lin JW, Chiu YC, Changchien CS, Wang CC, Chen YS, Yi LN, Chiu KW, Lee CM: Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese. World J Gastroenterol. 2006 Jan 28; 12(4):595-602.
11. Hata Y, Ishigami S, Natsugoe S, Nakajo A, Okumura H, Miyazono F, Matsumoto M, Hokita S, Aikou T: P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach. Hepatogastroenterology. 2006 Jul-Aug; 53(70):613-5. (Pubitemid 44386970)
12. Filiz G, Yalçinkaya O, Gürel S, Yerci O, Memik F: The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors. Hepatogastroenterology. 2007 Mar; 54(74):438-41. (Pubitemid 46724700)
13. Toquet C, Le Néel JC, Guillou L, Renaudin K, Hamy A, Heymann MF, Simon-Valla S, Le Borgne J, Maugard C, Fiche M: Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig Dis Sci. 2002 Oct; 47(10):2247-53. (Pubitemid 35205300)
14. Lopes LF, Bacchi CE: EGFR and gastrointestinal stromal tumor: an immunohistochemical and FISH study of 82 cases. Mod Pathol. 2007 Sep; 20(9):990-4. (Pubitemid 47267827)
15. Suster S: Gastrointestinal stromal tumors. Semin Diagn Pathol. 1996 Nov; 13(4):297-313.
16. Joensuu H: Gastrointestinal stromal tumor (GIST). Ann Oncol. 2006 Sep; 17 Suppl 10:x280-6.
17. Rubió J, Marcos-Gragera R, Ortiz MR, Miró J, Vilardell L, Gironès J, et al: Population-based incidence and survival of gastrointestinal stromal tumors (GIST) in Girona, Spain. Eur J Cancer. 2007 Jan; 43(1):144-8. (Pubitemid 46054472)
18. Lai IR, Chen CN, Lin MT, Lee PH: Surgical treatment of gastric gastrointestinal stromal tumors: analysis of 92 operated patients. Dig Surg. 2008; 25(3):208-12.
19. Tzen CY, Wang MN, Mau BL: Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors. Eur J Surg Oncol. 2008 May; 34(5):563-8.
20. Tsukuda K, Hirai R, Miyake T, Takagi S, Ikeda E, Kunitomo T, Tsuji H: The outcome of gastrointestinal stromal tumors (GIST) after a surgical resection in our institute. Surg Today. 2007; 37:953-957. (Pubitemid 47622209)
21. Yalcinkaya U, Yerci O, Koc EU: Significance of p53 expression in gastrointestinal stromal tumors. Hepatogastroenterology. 2007 Jan-Feb; 54(73): 140-3. (Pubitemid 46511663)